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Background:  Heart failure (CHF) is the most frequent and prognostically severe symptom of aortic stenosis (AS), and the most common indication 
for surgery. Aortic Jet Velocity (V2), Aortic valve area (AVA) and aortic valve area index (AVAI) are all used clinically to assess the severity of AS and 
predict its outcome, but there is no agreement on whether one index is superior. This study tries to identify the best echocardiographic index which is 
the best predictor of development of CHF in patients with known AS.
Methods:  This retrospective cohort study evaluated 532 patients with normal or mildly impaired LVEF and moderate or severe AS who had 925 
echoes performed over an 11 year period. Each echo was correlated with concurrent clinical assessments while blinding the investigator to the echo 
severity of AS. The Cox Proportional Hazards model was used to analyze the relationship of V2, AVA, and AVAI echocardiographic indices and the 
development of symptomatic CHF.
Results:  The average age of patients at entry was 76.1 years, with 54% males. A total of 116 patients (21.8%) developed new onset heart failure 
during follow-up. Jet velocity (1/V2) when taken alone, was highly predictive of the risk of heart failure (p<0.0001). When the term V1*A1, or product 
of inflow velocity (V1) and inflow area (A1), was incorporated along with 1/V2 yielding AVA, there was a statistically significant improvement in 
prediction of CHF (p=0.049). The inverse of body surface area, when used to index AVA, did not improve prediction of CHF (p= 0.319).
Conclusions:  AVA is a superior predictor of symptomatic heart failure when compared to jet velocity alone. Indexing the AVA by BSA (AVAI) does 
not add additional predictive value.
